financetom
Business
financetom
/
Business
/
Riley Exploration Permian Insider Sold Shares Worth $266,261, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Riley Exploration Permian Insider Sold Shares Worth $266,261, According to a Recent SEC Filing
Jun 12, 2024 1:32 PM

04:13 PM EDT, 06/12/2024 (MT Newswires) -- Bobby Riley, Director, CEO, on June 10, 2024, sold 10,020 shares in Riley Exploration Permian ( REPX ) for $266,261. Following the Form 4 filing with the SEC, Riley has control over a total of 381,658 shares of the company, with 381,658 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1001614/000175603024000010/xslF345X03/wk-form4_1718222772.xml

Price: 27.84, Change: +0.01, Percent Change: +0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Endeavour Down 1.2% In Early Afternoon UK Trade As Renews Normal Course Issuer Bid
Endeavour Down 1.2% In Early Afternoon UK Trade As Renews Normal Course Issuer Bid
Mar 20, 2025
08:26 AM EDT, 03/20/2025 (MT Newswires) -- Endeavour Mining plc ( EDVMF ) was at last look down 1.2% in early afternoon UK trade after saying Thursday it has received approval from the Toronto Stock Exchange to renew its Normal Course Issuer Bid for its share buyback programme, with respect to its ordinary shares in order to continue supplementing its...
Jabil raises 2025 profit, revenue forecast on data center demand
Jabil raises 2025 profit, revenue forecast on data center demand
Mar 20, 2025
March 20 (Reuters) - Electronic component maker Jabil ( JBL ) on Thursday raised its 2025 profit and revenue forecast, after beating Wall Street estimates for second-quarter results, helped by strong demand for data center infrastructure. Shares of the company rose 6.5% in premarket trading following the results. The rush to develop and adopt artificial intelligence has strengthened the global...
Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization
Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization
Mar 20, 2025
08:28 AM EDT, 03/20/2025 (MT Newswires) -- Candel Therapeutics ( CADL ) and IDEA Pharma said Thursday they have entered a commercial partnership to support the development and potential market launch of Candel's lead candidate CAN-2409. As part of the agreement, set to continue through next year, IDEA will provide strategic guidance as Candel prepares a biologics license application for...
Knight Therapeutics Swings to Q4 Profit, Revenue Advances
Knight Therapeutics Swings to Q4 Profit, Revenue Advances
Mar 20, 2025
08:32 AM EDT, 03/20/2025 (MT Newswires) -- Knight Therapeutics ( KHTRF ) on Thursday reported a swing to fourth-quarter profit as revenue rose 31%. The company reported net income was $10.7 million, compared with a loss of $24.3 million in the prior year period. Knight reported a net gain of $8.3 million helped by the revaluation of financial assets measured...
Copyright 2023-2026 - www.financetom.com All Rights Reserved